Depressive DisordersPTSDAnxiety DisordersInterpersonal Functioning & Social Connectedness

Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers

Analysing 403 forum posts, the study found that people who use psychedelics outside clinical settings prefer carers who demonstrate presence, trust and empathy. These user-derived insights largely support existing PAP guidelines but highlight “holding space” as a central practice and suggest nonclinical experience can help triangulate and extend treatment principles.

Authors

  • Stephen Bright

Published

Journal of Humanistic Psychology
individual Study

Abstract

Research into psychedelic-assisted psychotherapy (PAP) is rapidly increasing with best practice guidelines being continuously updated. Yet the key principals of such guidelines are based on evidence accumulated during earlier research into these treatments and trans-disciplinary psychotherapeutic knowledge. One area of practice-based evidence that has not been considered is that accumulated by people who use psychedelics (PWUP) outside of clinical contexts. We conducted a thematic analysis of 403 posts on two online discussion forums with the aim of gathering information regarding the preferences of PWUP for characteristics they value in their carers in nonclinical contexts. We found three key distinct characteristics that PWUP preferred among their carers: presence, trust, and empathy. The characteristics were often consistent with the existing literature on PAP, though at times extended current understandings of key characteristics of PAP therapists, with the notion of carers being able to “hold space” during the psychedelic experience seen as an integral component of effective therapeutic outcomes that deserves more attention. Data obtained from PWUP in nonclinical contexts can be used to triangulate existing principles contained within PAP treatment guidelines and identify areas for further investigation.

Available with Blossom Pro

Research Summary of 'Presence, Trust, and Empathy: Preferred Characteristics of Psychedelic Carers'

Introduction

The paper situates contemporary interest in psychedelic-assisted psychotherapy (PAP) within a long history of psychedelic research that was interrupted by regulatory restrictions in the 1970s but has resumed in recent decades. Clinical investigations have explored PAP for disorders such as substance-use disorders, anxiety, depression and PTSD, and have emphasised that therapeutic support and the quality of the acute psychedelic experience are crucial determinants of longer-term outcomes. Despite growing guidance on PAP and emerging therapist training programmes, empirical evidence about the personal characteristics and competencies required of therapists and nonclinical carers remains limited. S. and colleagues sought to address this gap by drawing on practice-based evidence held by people who use psychedelics (PWUP) outside clinical settings. Specifically, the researchers conducted a qualitative thematic analysis of online forum posts to identify the characteristics PWUP prefer in carers or “trip sitters” in recreational/nonclinical contexts, with the aim of comparing these preferences to characteristics described in the clinical PAP literature and thereby informing best-practice training and guidance.

Expert Research Summaries

Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.

Study Details

References (21)

Papers cited by this study that are also in Blossom

Development of a Psychotherapeutic Model for Psilocybin-Assisted Treatment of Alcoholism

Bogenschutz, M. P., Forcehimes, A. A. · Journal of Humanistic Psychology (2016)

Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study

Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A. et al. · Journal of Psychopharmacology (2015)

Trial of Psilocybin versus Escitalopram for Depression

Carhart-Harris, R. L., Giribaldi, B., Watts, R. et al. · New England Journal of Medicine (2021)

927 cited
Serotonin and brain function: a tale of two receptors

Carhart-Harris, R. L., Nutt, D. J. · Journal of Psychopharmacology (2017)

Psychedelics and the essential importance of context

Carhart-Harris, R. L., Roseman, L., Haijen, E. C. H. M. et al. · Journal of Psychopharmacology (2018)

Clinical Applications of Hallucinogens: A Review

Garcia-Romeu, A., Kersgaard, B., Addy, P. H. · Experimental and Clinical Psychopharmacology (2016)

174 cited
Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions

Richards, W. A., Garcia-Romeu, A. · International Review of Psychiatry (2018)

Show all 21 references
Constructing drug effects: a history of set and setting

Hartogsohn, I. · Drug Science Policy and Law (2017)

389 cited
Human hallucinogen research: guidelines for safety

Johnson, M. W., Richards, W. A., Griffiths, R. R. · Journal of Psychopharmacology (2008)

Psychedelic Psychotherapy Insights From 25 Years of Research

Richards, W. A. · Journal of Humanistic Psychology (2016)

Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression

Roseman, L., Nutt, D. J., Carhart-Harris, R. L. · Frontiers in Pharmacology (2018)

Psilocybin-assisted therapy of major depressive disorder using Acceptance and Commitment Therapy as a therapeutic frame

Sloshower, J., Guss, J., Krause, R. et al. · Journal of Contextual Behavioral Science (2020)

Patients’ accounts of increased “Connectedness” and “Acceptance” after psilocybin for treatment-resistant depression

Watts, R., Day, C. M., Krzanowski, J. et al. · Journal of Humanistic Psychology (2017)

Cited By (5)

Papers in Blossom that reference this study

Mapping the phenomenology of intranasal 5-MeO-DMT in psychedelic-naïve healthy adults

Ermakova, A. O., Dunbar, F., Seynaeve, M. et al. · Scientific Reports (2025)

3 cited
Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study

Breeksema, J. J., Niemeijer, A. R., Krediet, E. et al. · Scientific Reports (2024)

Dosing and Therapeutic Conduct in Administration Sessions in Substance-Assisted Psychotherapy: A Systematized Review

Thal, S. B., Wieberneit, M., Sharbanee, J. M. et al. · Journal of Humanistic Psychology (2023)

4 cited

Your Personal Research Library

Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.